Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

64.60p
   
  • Change Today:
      0.100p
  • 52 Week High: 64.60
  • 52 Week Low: 29.35
  • Currency: UK Pounds
  • Shares Issued: 540.57m
  • Volume: 1,165,679
  • Market Cap: £349.21m
  • RiskGrade: 119
  • Beta: 0.01

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
25.13% below the market average25.13% below the market average25.13% below the market average25.13% below the market average25.13% below the market average
60% below the sector average60% below the sector average60% below the sector average60% below the sector average60% below the sector average
1yr Revenue Growth
27.59% below the market average27.59% below the market average27.59% below the market average27.59% below the market average27.59% below the market average
48.39% below the sector average48.39% below the sector average48.39% below the sector average48.39% below the sector average48.39% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
4.77% below the market average4.77% below the market average4.77% below the market average4.77% below the market average4.77% below the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average
Price Book Ratio
36.79% below the market average36.79% below the market average36.79% below the market average36.79% below the market average36.79% below the market average
26.83% above the sector average26.83% above the sector average26.83% above the sector average26.83% above the sector average26.83% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
12.35% above the market average12.35% above the market average12.35% above the market average12.35% above the market average12.35% above the market average
8.33% below the sector average8.33% below the sector average8.33% below the sector average8.33% below the sector average8.33% below the sector average
Price Chg 3m
55.40% above the market average55.40% above the market average55.40% above the market average55.40% above the market average55.40% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
89.11% above the market average89.11% above the market average89.11% above the market average89.11% above the market average89.11% above the market average
86.67% above the sector average86.67% above the sector average86.67% above the sector average86.67% above the sector average86.67% above the sector average
Momentum 20
15.67% above the market average15.67% above the market average15.67% above the market average15.67% above the market average15.67% above the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
46.19% below the market average46.19% below the market average46.19% below the market average46.19% below the market average46.19% below the market average
25.71% above the sector average25.71% above the sector average25.71% above the sector average25.71% above the sector average25.71% above the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
10.60% above the market average10.60% above the market average10.60% above the market average10.60% above the market average10.60% above the market average
62.50% above the sector average62.50% above the sector average62.50% above the sector average62.50% above the sector average62.50% above the sector average
Forecast EPS
64.09% below the market average64.09% below the market average64.09% below the market average64.09% below the market average64.09% below the market average
77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
37.91% above the market average37.91% above the market average37.91% above the market average37.91% above the market average37.91% above the market average
54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average
Operating Profit Loss
81.11% below the market average81.11% below the market average81.11% below the market average81.11% below the market average81.11% below the market average
41.67% below the sector average41.67% below the sector average41.67% below the sector average41.67% below the sector average41.67% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
40.93% above the market average40.93% above the market average40.93% above the market average40.93% above the market average40.93% above the market average
53.19% above the sector average53.19% above the sector average53.19% above the sector average53.19% above the sector average53.19% above the sector average
Cash
44.40% above the market average44.40% above the market average44.40% above the market average44.40% above the market average44.40% above the market average
57.45% above the sector average57.45% above the sector average57.45% above the sector average57.45% above the sector average57.45% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
93.58% below the market average93.58% below the market average93.58% below the market average93.58% below the market average93.58% below the market average
86.67% below the sector average86.67% below the sector average86.67% below the sector average86.67% below the sector average86.67% below the sector average
Brokers Percent Neutral
79.82% above the market average79.82% above the market average79.82% above the market average79.82% above the market average79.82% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 64.60p
Change Today 0.100p
% Change 0.16 %
52 Week High 64.60
52 Week Low 29.35
Volume 1,165,679
Shares Issued 540.57m
Market Cap £349.21m
Beta 0.01
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
23.31% above the market average23.31% above the market average23.31% above the market average23.31% above the market average23.31% above the market average
95.83% above the sector average95.83% above the sector average95.83% above the sector average95.83% above the sector average95.83% above the sector average
Price Trend
76.92% above the market average76.92% above the market average76.92% above the market average76.92% above the market average76.92% above the market average
79.17% above the sector average79.17% above the sector average79.17% above the sector average79.17% above the sector average79.17% above the sector average
Income Not Available
Growth
50.08% below the market average50.08% below the market average50.08% below the market average50.08% below the market average50.08% below the market average
68.75% below the sector average68.75% below the sector average68.75% below the sector average68.75% below the sector average68.75% below the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 5
Sell 1
Strong Sell 0
Total 8
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 02-May-2025

Time Volume / Share Price
16:30 14 @ 64.50p
16:30 13 @ 64.50p
16:35 104,626 @ 64.60p
16:35 249 @ 64.60p
16:35 279 @ 64.60p

Alliance Pharma Key Personnel

CFO Andrew Franklin
Chair Camillo Pane
CEO Nick Sedgwick

Top of Page